Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2026-01-22 00:00:00 ET · period of report 2026-01-20 · accession 0001856369-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-22 | 2026-01-20 | RXRX | Gibson Christopher | Dir | C - Cnv Deriv | $0.00 | +40.0K | 953.8K | +4% | $0 |
| D | 2026-01-22 | 2026-01-20 | RXRX | Gibson Christopher | Dir | S - Sale | $4.47 | -40.0K | 913.8K | -4% | -$178.8K |
| D | 2026-01-22 | 2026-01-20 | RXRX | Gibson Christopher | Dir | C - Cnv Deriv | $0.00 | -40.0K | 4.62M | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-20 | C | A | 40,000 | $0.00 | 953,839 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-01-20 | S | D | 40,000 | $4.47 | 913,839 | D | — | — | |
| 3 | Derivative | Class B Common Stock | 2026-01-20 | C | D | 40,000 | $0.00 | 4,623,334 | D | $0.00 · — to — | 40,000 Class A Common Stock | (F1) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. |